tiprankstipranks
Trending News
More News >
ImmunityBio (IBRX)
NASDAQ:IBRX

ImmunityBio (IBRX) Revenue

Compare
2,284 Followers

ImmunityBio Revenue

ImmunityBio had a revenue of 38.28M in the quarter ending Dec 31, 2025, with 19.41%. This bring the company's revenue in the last twelve months to 113.29M, Decreased 37.23%. In the fiscal year ending Dec 31, 2025, ImmunityBio had annual revenue of 113.29M with 668.31% growth.
Revenue (ttm)
113.29M
Revenue Growth
1025.95%
P/S Ratio
90.75
Revenue/Employee
$168,835
Employees
671
Market Cap
$10.28B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
113.29M98.54M+668.31%
Dec 31, 2024
14.74M14.12M+2,270.58%
Dec 31, 2023
622.00K382.00K+159.17%
Dec 31, 2022
240.00K-694.00K-74.30%
Dec 31, 2021
934.00K329.00K+54.38%
Dec 31, 2020
605.00K562.00K+1,306.98%
Dec 31, 2019
43.00K-4.00K-8.51%
Dec 31, 2018
47.00K2.00K+4.44%
Dec 31, 2017
45.00K